Psilocybin in Alberta: the law in Calgary and Edmonton, and the province’s psychedelic therapy rules

People in Calgary and Edmonton often ask whether Alberta treats psilocybin differently from the rest of Canada. The answer has two parts. The drug itself is controlled by federal law, which applies in Alberta exactly as it does in Ontario or British Columbia. Alberta has then added its own rules for clinics that use psychedelic drugs in mental health treatment. Our Ontario guide found no comparable Ontario framework; we did not check every province.

This guide takes the federal layer first, then Alberta’s rules, then what those rules do not mean, then research with Alberta sites, and ends with where to get help. It is general information, not legal or medical advice, and it says nothing about how to obtain any drug.

Is psilocybin legal in Alberta?

No. Health Canada states that the production, sale and possession of magic mushrooms are illegal in Canada, and that these activities can only be authorized by Health Canada under the Controlled Drugs and Substances Act (CDSA) (Health Canada, page modified 20 October 2026, re-read 24 October 2026). Nothing in that statement is limited to one province, so it applies in Calgary, Edmonton and everywhere else in Alberta.

The legal basis is the CDSA. Its Schedule III lists psilocin and psilocybin, each “and any salt thereof”. Section 4(1) says that, except as authorized under the regulations, no person shall possess a substance in Schedule I, II or III. Section 5 prohibits trafficking and possession for the purpose of trafficking, and section 7 prohibits production (Justice Laws, CDSA, current to 30 September 2026, read 17 October 2026). Our national guide, are magic mushrooms legal in Canada?, covers the federal picture in more depth.

Health Canada also says there are currently no approved therapeutic products containing psilocybin in Canada or elsewhere (Health Canada). That matters for Alberta’s rules below: the province regulates how clinics may use these drugs, but it has not approved a psilocybin medicine, and it could not do so on its own.

What does federal law provide for Schedule III offences?

These are statutory maximums, not predictions. A court sets any actual sentence on the facts. Under the CDSA as read on 17 October 2026 (CDSA):

• Possession of a Schedule III substance (section 4(6)): on indictment, up to three years’ imprisonment; on summary conviction, a fine of up to $1,000 or up to six months, or both, for a first offence, and up to $2,000 or one year, or both, for a subsequent offence.
• Trafficking or possession for the purpose of trafficking (section 5(3)(b)): on indictment, up to ten years; on summary conviction, up to eighteen months.
• Production (section 7): the same ranges as trafficking for a Schedule III substance, as summarized in our penalties guide.

The CDSA also asks police to think before charging simple possession. Section 10.2 says that where a peace officer could lay an information for possession, the officer must consider whether it would be preferable to take no further action, to warn the person, or, with consent, to refer them to a program or service (CDSA). That is a duty to consider options, not a legal exemption. Possession remains an offence in Alberta.

What about driving?

Section 320.14(1)(a) of the Criminal Code makes it an offence to operate a conveyance while your ability is impaired to any degree by alcohol or a drug. Paragraph (1)(c) adds an offence for having, within two hours after ceasing to operate a conveyance, a blood drug concentration at or above the prescribed level (Criminal Code s. 320.14, current to 30 September 2026). For psilocybin and psilocin the prescribed level is “any detectable level” (Blood Drug Concentration Regulations). Alberta also has its own traffic laws with administrative penalties, but we did not check them for this article. Nobody should drive while impaired.

Did the federal regulations of 1 October 2026 change this?

Not the basic position, as far as we could find. The Controlled Substances Regulations (SOR/2025-242) were registered on 28 November 2025 and, under their section 239, came into force on 1 October 2026. Psilocin and psilocybin appear in their Schedule 4 (Restricted Drugs), and the regulatory impact statement says the initiative does not change the overall policy intent and the key elements of the framework for controlled substances (Canada Gazette, Part II, 17 December 2025, read 17 October 2026). We found nothing in them that makes possession, sale or production by the general public lawful in Alberta or anywhere else.

What are Alberta’s own psychedelic therapy rules?

Alberta regulates psychedelic drug treatment as a health service. The rules sit in Part 3 of the Mental Health Services Protection Regulation (Alberta Regulation 114/2021), made under the Mental Health Services Protection Act. Part 3 was added by an amendment, Alberta Regulation 202/2022. We read the King’s Printer office consolidation current as of 4 June 2026 (Alberta Regulation 114/2021).

Alberta’s fact sheet says the government introduced the requirements in October 2022 and that they came into effect on 16 January 2023 (Alberta fact sheet, 5 October 2022). The detailed operating requirements are in the Psychedelic Drug Treatment Services Standards, dated 16 January 2023, which set the minimum requirements a licensed provider must meet (Alberta Standards).

Which drugs are covered?

The regulation defines “designated psychedelic drug” to include MDMA, ketamine, LSD, mescaline, DMT, 5-methoxy DMT, psilocin and psilocybin, whether synthesized or naturally occurring (section 33). It applies to “psychedelic drug treatment services”, defined as services to treat a psychiatric disorder that include one or more of those drugs (Alberta Regulation 114/2021). The fact sheet says the regulation does not apply to clinical research trials or to psychedelic-assisted therapy used for pain, palliative care or other illnesses (Alberta fact sheet).

Licence, medical director and prescribers

• Licence: a service provider who offers or provides psychedelic drug treatment services needs a licence, unless an exemption applies (sections 34 and 35) (Alberta Regulation 114/2021).
• Medical director: a licensed provider must appoint a medical director to oversee all clinically related aspects of the services, and the medical director must be a psychiatrist authorized to provide these services, with the qualifications the Standards require (section 40) (Alberta Regulation 114/2021).
• Prescribing: no one may prescribe a designated psychedelic drug to treat a psychiatric disorder unless they are a psychiatrist trained as the Standards require, or a physician prescribing after and with ongoing consultation with a psychiatrist. Ketamine outside psychedelic-assisted psychotherapy is treated differently (section 36) (Alberta Regulation 114/2021).
• Psychotherapists: people providing the psychotherapy must belong to one of six named regulatory colleges, be authorized for psychosocial intervention, and meet education or experience and training requirements (section 38) (Alberta Regulation 114/2021).

Where the drug is given, and monitoring

For a psychedelic dose of a drug other than ketamine, or any designated drug used in psychedelic-assisted psychotherapy, the patient must be given the drug at an approved hospital, an accredited medical facility, or the facility of a licensed provider, with an exception for patients at or near the end of life. The patient must be monitored, treated and cared for while in an altered state of consciousness (section 37) (Alberta Regulation 114/2021). The Standards say that monitoring must be continuous (section 10) (Alberta Standards). In general, no one may dispense or sell a designated psychedelic drug directly to a patient; the regulation’s narrow exceptions concern prescribed non-psychedelic doses and some ketamine formulations outside psychotherapy (section 37) (Alberta Regulation 114/2021).

The College of Physicians & Surgeons of Alberta (CPSA) adds its own layer for physicians. In August 2023 it announced accreditation standards for psychedelic-assisted psychotherapy facilities and said that, before facilities may provide this therapy, they must be assessed and accredited by CPSA (CPSA, 10 August 2023). We read the announcement, not the accreditation standards themselves, which CPSA says it sends to facilities that register for assessment.

Consent and records

Under the Standards, a patient is eligible only if the prescriber has decided the treatment is in their best interests and the patient has capacity to consent (section 2). The consent process must cover the experimental nature of the treatment, its potential benefits and all its risks, and the evidence on both (section 4). Providers must keep records, including documentation of any relevant authorization obtained to provide the service, “including any authorizations under the Controlled Drugs and Substances Act (Canada) or the Food and Drugs Act (Canada)” (section 27) (Alberta Standards).

Alberta publishes a directory of licensed providers, and the directory page says providers must post their licence at each facility and on their website, and that anyone who thinks a provider may be operating without a licence can contact the province’s compliance team. We list no providers here, and a listing is not an endorsement.

How do the federal and Alberta layers fit together?

Think of two separate permissions. Ottawa decides whether a person may lawfully possess, sell, produce or administer psilocybin at all. Alberta decides how a clinic must be set up and run if it treats psychiatric disorders with psychedelic drugs. One does not replace the other.

The federal column is from Health Canada’s list of three pathways (clinical trials, the Special Access Program and individual subsection 56(1) exemptions) and the CDSA (Health Canada; CDSA). Our guides to the Special Access Program and section 56 exemptions explain each route.

Does an Alberta licence make psilocybin legal for a clinic? Nothing we read says it does. Alberta’s licensing page does not mention Health Canada or federal law at all (Alberta licensing page). In the regulation, the only reference to the CDSA we found is in a different Part, which requires supervised consumption sites to hold a federal exemption; Part 3 on psychedelic drugs does not mention the CDSA (Alberta Regulation 114/2021). The Standards, by asking clinics to record any CDSA or Food and Drugs Act authorizations, treat federal permission as a separate matter (Alberta Standards). We found no Alberta or federal sentence stating outright that a provincial licence does or does not authorize the drug under the CDSA, so we do not make that claim. Our guide to psilocybin-assisted therapy in Canada discusses the same gap.

What Alberta’s rules do not mean

• They do not legalize magic mushrooms. The federal offences in the CDSA apply in Alberta exactly as elsewhere (CDSA).
• They do not authorize stores or dispensaries. The regulation licenses treatment services for psychiatric disorders, and its general rule is that a designated psychedelic drug may not be sold directly to a patient (Alberta Regulation 114/2021). Health Canada says sale is illegal unless it authorizes it (Health Canada). A storefront in Calgary or Edmonton is not made lawful by Alberta’s clinic framework.
• They do not create a right to treatment. Eligibility depends on a prescriber’s judgement and the patient’s capacity to consent (Alberta Standards), and access to the drug still runs through a federal route.
• They do not approve psilocybin as a medicine. Health Canada says no psilocybin product is approved (Health Canada), and Alberta’s Standards require patients to be told the treatment is experimental (Alberta Standards).
• They do not cover recreational use, wellness retreats or treatment of non-psychiatric conditions. The regulation is limited to treating psychiatric disorders (Alberta fact sheet).

We did not search for or verify specific enforcement cases in Calgary or Edmonton for this article, and we do not describe local police priorities. Statements about priorities, where they exist, are not law and do not create an exemption.

What psilocybin research is happening in Alberta?

On 17 October 2026 we queried the ClinicalTrials.gov registry for studies matching “psilocybin” with a location in Alberta. It returned six studies, all interventional, and every Alberta site listed was in Calgary (ClinicalTrials.gov API). The same query with Edmonton as the location returned none. A registry listing is a plan, not a result, and status fields depend on sponsors keeping them up to date.

Evidence label: these are registered studies, not findings. None of them, on its own, shows that psilocybin works for any condition. Our article on psilocybin and alcohol use disorder trials looks at what has and has not been published in that area.

Alberta’s rules interact with research in a specific way. A provider is exempt from the clinic licence when it offers psychedelic drug treatment in an approved clinical research trial, follows the research ethics board’s conditions, and charges participants nothing (section 35). It must still report the trial to the province within 60 days of ethics approval, including the investigators, drugs, indications, setting and a summary (section 47) (Alberta Regulation 114/2021; Alberta licensing page). Federal approval of the trial is a separate requirement, as Health Canada describes clinical trials as one of its own pathways (Health Canada).

Where can Albertans get help?

If you are worried about your own substance use or someone else’s, these services are free. We checked each number on an official page on 17 October 2026.

• Emergency: call 911.
• Health Link 811: Alberta Health Services describes 811 as a free health information service for advice at any hour, and says you can dial 811 and follow the prompts to reach its Addiction and Mental Health team (Alberta Health Services).
• Addiction Helpline: Alberta Health Services lists a 24-hour Helpline at 1-866-332-2322 (Alberta only) for information and to find an addiction services office (Alberta Health Services).
• 211 Alberta: Recovery Alberta lists 2-1-1 as available 24 hours a day, 7 days a week and confidential, for finding services near you (Recovery Alberta).
• 9-8-8 Suicide Crisis Helpline: call or text 9-8-8, 24 hours a day, every day of the year (988.ca; Recovery Alberta).

If you are interested in a clinical trial, the safest first step is to talk to your own doctor, who can look at the registry entry with you and judge whether it is suitable. Health Canada says the lawful routes involve a regulated health care practitioner (Health Canada).

What is unknown or could not be confirmed?

• Whether an Alberta licence, on its own, has any effect under federal law. We found no official statement either way.
• How many licensed providers there are. The provincial directory loads its list dynamically and we could not reliably count it, so we give no number.
• The content of CPSA’s facility accreditation standards. We read CPSA’s announcement only.
• Alberta traffic-law penalties for drug-impaired driving. We did not check the Traffic Safety Act for this article.
• Local enforcement in Calgary and Edmonton. We did not verify any recent cases or police statements.
• Whether the trial statuses above are current. Registry fields are self-reported and can lag.

Where should you check the current position?

• Health Canada’s psilocybin page, for the federal position and the three access routes.
• Justice Laws, for the CDSA and the Criminal Code, each of which states how current it is.
• Alberta King’s Printer, for the current consolidation of the Mental Health Services Protection Regulation.
• Alberta’s licensing page and provider directory, for the provincial framework.
• ClinicalTrials.gov, for current trial listings.
• A licensed Alberta lawyer, for any actual situation.

For comparison with other provinces, see Ontario and British Columbia, and for other countries, our world overview and the psilocybin law tracker.

Shroomverse sells mushroom products. This article is general information about Canadian and Alberta law. It is not legal or medical advice, and it does not encourage anyone to use drugs.